Effects of Rifampicin, Dexamethasone, St. John's Wort and Thyroxine on Maternal and Foetal Expression of Abcb1 and Organ Distribution of Talinolol in Pregnant Rats

Basic and Clinical Pharmacology and Toxicology

Volumn 111, Issue 2, 2012, Pages 99-105

  Saljé, Karen ^a   Lederer, Kirstin ^a   Oswald, Stefan ^a   Dazert, Eike ^a   Warzok, Rolf ^a   Siegmund, Werner ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYPERICUM PERFORATUM EXTRACT; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; RIFAMPICIN; TALINOLOL; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; GESTATIONAL AGE; HEART; JEJUNUM; KIDNEY; LIVER; NONHUMAN; ORGAN DISTRIBUTION; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMALL INTESTINE; TISSUE DISTRIBUTION;

ADMINISTRATION, ORAL; ANIMALS; BRAIN; DEXAMETHASONE; FEMALE; FETUS; HYPERICUM; LIVER; P-GLYCOPROTEINS; PLACENTA; PREGNANCY; PROPANOLAMINES; RATS; RATS, WISTAR; RIFAMPIN; RNA, MESSENGER; THYROXINE;

RATTUS; RATTUS NORVEGICUS;

EID: 84863994775     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2012.00866.x     Document Type: Article

References (36)

1. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 2003;55:3-29.
2. Sarkadi B, Homolya L, Szakacs G, Varadi A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev 2006;86:1179-236.
3. Behravan J, Piquette-Miller M. Drug transport across the placenta, role of the ABC drug efflux transporters. Expert Opin Drug Metab Toxicol 2007;3:819-30.
4. Ceckova-Novotna M, Pavek P, Staud F. P-glycoprotein in the placenta: expression, localization, regulation and function. Reprod Toxicol 2006;22:400-10.
5. Atkinson DE, Greenwood SL, Sibley CP, Glazier JD, Fairbairn LJ. Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer. Am J Physiol Cell Physiol 2003;285:C584-91.
6. Lankas GR, Wise LD, Cartwright ME, Pippert T, Umbenhauer DR. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 1998;12:457-63.
7. Smit JW, Huisman MT, van Tellingen O, Wiltshire HR, Schinkel AH. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 1999;104:1441-7.
8. Sudhakaran S, Ghabrial H, Nation RL, Kong DC, Gude NM, Angus PW et al.Differential bidirectional transfer of indinavir in the isolated perfused human placenta. Antimicrob Agents Chemother 2005;49:1023-8.
9. Molsa M, Heikkinen T, Hakkola J, Hakala K, Wallerman O, Wadelius M et al.Functional role of P-glycoprotein in the human blood-placental barrier. Clin Pharmacol Ther 2005;78:123-31.
10. Nekhayeva IA, Nanovskaya TN, Deshmukh SV, Zharikova OL, Hankins GD, Ahmed MS. Bidirectional transfer of methadone across human placenta. Biochem Pharmacol 2005;69:187-97.
11. May K, Minarikova V, Linnemann K, Zygmunt M, Kroemer HK, Fusch C et al.Role of the multidrug transporter proteins ABCB1 and ABCC2 in the diaplacental transport of talinolol in the term human placenta. Drug Metab Dispos 2008;36:740-4.
12. Rosati A, Maniori S, Decorti G, Candussio L, Giraldi T, Bartoli F. Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 2003;45:377-87.
13. Cui YJ, Cheng X, Weaver YM, Klaassen CD. Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice. Drug Metab Dispos 2009;37:203-10.
14. Westphal K, Weinbrenner A, Zschiesche M, Franke G, Knoke M, Oertel R et al.Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction. Clin Pharmacol Ther 2000;68:345-55.
15. Spahn-Langguth H, Baktir G, Radschuweit A, Okyar A, Terhaag B, Ader P et al.P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound. Int J Clin Pharmacol Ther 1998;36:16-24.
16. Zhou SF. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008;38:802-32.
17. Tirona RG, Kim RB. Nuclear receptors and drug disposition gene regulation. J Pharm Sci 2005;94:1169-86.
18. Tirona RG, Leake BF, Podust LM, Kim RB. Identification of amino acids in rat pregnane X receptor that determine species-specific activation. Mol Pharmacol 2004;65:36-44.
19. Sandstrom R, Lennernas H. Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats. Drug Metab Dispos 1999;27:951-5.
20. Salphati L, Benet LZ. Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers. Biochem Pharmacol 1998;55:387-95.
21. Kageyama M, Fukushima K, Togawa T, Fujimoto K, Taki M, Nishimura A et al.Relationship between excretion clearance of rhodamine 123 and P-glycoprotein (Pgp) expression induced by representative Pgp inducers. Biol Pharm Bull 2006;29:779-84.
22. Kamiya A, Inoue Y, Gonzalez FJ. Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology 2003;37:1375-84.
23. Vyhlidal CA, Gaedigk R, Leeder JS. Nuclear receptor expression in fetal and pediatric liver: correlation with CYP3A expression. Drug Metab Dispos 2006;34:131-7.
24. de Zwart L, Scholten M, Monbaliu JG, Annaert PP, Van Houdt JM, Van den Wyngaert I et al.The ontogeny of drug metabolizing enzymes and transporters in the rat. Reprod Toxicol 2008;26:220-30.
25. Fardel O, Lecureur V, Loyer P, Guillouzo A. Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells. Biochem Pharmacol 1995;49:1255-60.
26. Zong J, Pollack GM. Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin. J Pharmacol Exp Ther 2003;306:556-62.
27. Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology 2002;36:164-72.
28. Zheng HX, Huang Y, Frassetto LA, Benet LZ. Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite. Clin Pharmacol Ther 2009;85:78-85.
29. Lam JL, Shugarts SB, Okochi H, Benet LZ. Elucidating the effect of final-day dosing of rifampin in induction studies on hepatic drug disposition and metabolism. J Pharmacol Exp Ther 2006;319:864-70.
30. Shirasaka Y, Li Y, Shibue Y, Kuraoka E, Spahn-Langguth H, Kato Y et al.Concentration-dependent effect of naringin on intestinal absorption of beta(1)-adrenoceptor antagonist talinolol mediated by p-glycoprotein and organic anion transporting polypeptide (Oatp). Pharm Res 2009;26:560-7.
31. Novotna M, Libra A, Kopecky M, Pavek P, Fendrich Z, Semecky V et al.P-glycoprotein expression and distribution in the rat placenta during pregnancy. Reprod Toxicol 2004;18:785-92.
32. Gil S, Saura R, Forestier F, Farinotti R. P-glycoprotein expression of the human placenta during pregnancy. Placenta 2005;26:268-70.
33. Kalabis GM, Kostaki A, Andrews MH, Petropoulos S, Gibb W, Matthews SG. Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection. Biol Reprod 2005;73:591-7.
34. Coles LD, Lee IJ, Hassan HE, Eddington ND. Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice. J Pharm Sci 2009;98:2832-46.
35. Petropoulos S, Kalabis GM, Gibb W, Matthews SG. Functional changes of mouse placental multidrug resistance phosphoglycoprotein (ABCB1) with advancing gestation and regulation by progesterone. Reprod Sci 2007;14:321-8.
36. Holcberg G, Sapir O, Tsadkin M, Huleihel M, Lazer S, Katz M et al.Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil in human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 2003;109:133-7.